Pragmatic Research of Acupuncture and Counseling eXtended to Inpatient Services (PRACXIS)
21 octobre 2021 mis à jour par: University of California, San Francisco
Non-pharmacologic Approaches to Relieve Pain and Symptom Distress Among Diverse Hospitalized Cancer Patients
Despite improved assessment and pharmacologic management, cancer pain is still undertreated.
Using non-pharmacologic treatments alongside medications may better address patients' total pain experience by relieving physical and psychological symptoms and reducing the adverse effects of drugs.
However, our knowledge of the benefits of multidisciplinary approaches in real-world hospital settings is limited.
Patients want to know "How can I get the most pain relief with the fewest side effects?"
This study proposal is designed to address this question by testing how combining pharmacologic and non-pharmacologic (acupuncture and pain counseling) treatments can: (1) maximize effectiveness, (2) minimize harms, and (3) align with patients' preferences.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
This study compares clinically-relevant therapeutic options in two high-volume hospitals (one public, one university) to address the core research question of whether non-pharmacologic approaches improve symptom management among diverse inpatients. Study investigators will assess the effectiveness of acupuncture and of pain counseling independently and in combination.
Participants will be randomized to two factors each with two levels, yielding four experimental conditions: (1) standard pharmacologic pain management, (2) pharmacologic pain management + acupuncture, (3) pharmacologic pain management + pain counseling, (4) pharmacologic pain management + acupuncture + pain counseling. Patient outcomes will be assessed using a mixed-methods approach, with validated scales for quantitative measures and qualitative interviews to elicit stakeholder perspectives (patients, caregivers, providers).
The study will be conducted as a pragmatic clinical trial at two hospitals to address these aims:
- Determine the effectiveness of adjunctive acupuncture and of pain counseling for improving pain management.
- Determine the extent that adjunctive acupuncture and pain counseling reduce use of opioid analgesics and side effects.
- Examine stakeholder perspectives on non-pharmacologic approaches to pain management.
Type d'étude
Interventionnel
Inscription (Réel)
448
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
California
-
San Francisco, California, États-Unis, 94143
- University of California, San Francisco
-
San Francisco, California, États-Unis, 94110
- Zuckerberg San Francisco General Hospital
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
21 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Patients admitted to University of California San Francisco (UCSF) or Zuckerberg San Francisco General (ZSFG) with a malignant solid tumor
- Speak Cantonese, English, or Spanish
- Have an anticipated stay of ≥ 48 hours
- Be aged 21 or older
- Have pain intensity of ≥ 4 out of 10 for worst pain in the prior 24 hours when enrolled
Exclusion Criteria:
- Acupuncture contraindication
- Unstable medical condition (e.g., severe pulmonary disease, myocardial infarction)
- Admission to the psychiatric ward (e.g., for severe depression)
- Inability to consent (e.g., cognitive impairment)
- Prior involvement with the study (e.g., readmissions)
- Platelets < 50,000 microliters
- Absolute neutrophil count < 500 microliters
- C. difficile infection
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation factorielle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Treatment As Usual
Participants will receive routine care consisting of usual analgesic medications for pain in adults with cancer.
|
|
|
Comparateur actif: Acupuncture
Along with routine pain medications, participants will be offered daily acupuncture treatments for up to four days.
|
A licensed acupuncturist will assess participants' symptoms and administer acupuncture needles in accordance with traditional Chinese medicine principles and the study protocol.
Treatments will provided daily for up to four hospital days.
|
|
Comparateur actif: Pain Counseling
Along with routine pain medications, participants will receive evidence-based psychosocial support through education and counseling provided by qualified study staff.
|
Participants will receive sessions with a counselor trained in pain management.
The pain counselor will explain, review, and discuss the contents of a Pain Control booklet.
Sessions will include pain assessment, pain education, and coping skills, provided daily for up to four hospital days.
|
|
Comparateur actif: Acupuncture and Pain Counseling
Along with routine pain medications, participants will be offered daily acupuncture treatments and pain counseling for up to four days as described above.
|
A licensed acupuncturist will assess participants' symptoms and administer acupuncture needles in accordance with traditional Chinese medicine principles and the study protocol.
Treatments will provided daily for up to four hospital days.
Participants will receive sessions with a counselor trained in pain management.
The pain counselor will explain, review, and discuss the contents of a Pain Control booklet.
Sessions will include pain assessment, pain education, and coping skills, provided daily for up to four hospital days.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in worst pain intensity assessed by the NRS
Délai: Daily for up to four hospital days
|
Participants' worst level of pain in the past 24 hours on a 0-10 numeric rating scale (NRS), 0= no pain and 10= worst pain imaginable
|
Daily for up to four hospital days
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Use of opioids during hospital stay
Délai: Hospital stay (average length of stay = 5 days)
|
Total and average daily use of opioids based on morphine milligram equivalence
|
Hospital stay (average length of stay = 5 days)
|
|
Presence and severity of common side effects
Délai: Daily for up to four hospital days
|
Nausea, vomiting, agitation, and sedation
|
Daily for up to four hospital days
|
|
Cancer-related distress
Délai: Daily for up to four hospital days
|
Single item measure developed by the National Comprehensive Cancer Network.
Participants are asked to indicate the number that best describes how much distress they are experiencing in the past week including today, 0=no distress and 10=extreme distress.
|
Daily for up to four hospital days
|
|
Health-related quality of life assessed by the EuroQol EQ-5D-3L (EQ-5D-3L)
Délai: Daily for up to four hospital days
|
The EuroQol EQ-5D-3L descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 3 levels: no problems, some problems, extreme problems.
The respondent is asked to indicate his/her health state by ticking (or placing a cross) in the box against the most appropriate statement in each of the 5 dimensions.
The EuroQol visual analogue scale (EQ VAS) records the respondent's self-rated health on a vertical, visual analogue scale where the endpoints are labelled 'Best imaginable health state' and 'Worst imaginable health state'.
Detailed scoring instructions are available: https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-3L_UserGuide_2015.pdf
|
Daily for up to four hospital days
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Pain Treatment Satisfaction Scale
Délai: Assessed once at the end of hospital stay (average length of stay = 5 days)
|
The Pain Treatment Satisfaction Scale includes subscales of satisfaction with information, medical care, effectiveness, and side effects with reliability ranging from 0.83 to 0.92.
Each of the subscales are scored from 0 to 100 with higher scores indicating greater satisfaction.
|
Assessed once at the end of hospital stay (average length of stay = 5 days)
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Maria T Chao, DrPH, MPA, University of California, San Francisco
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
17 janvier 2019
Achèvement primaire (Réel)
30 septembre 2021
Achèvement de l'étude (Réel)
30 septembre 2021
Dates d'inscription aux études
Première soumission
30 août 2018
Première soumission répondant aux critères de contrôle qualité
3 avril 2019
Première publication (Réel)
5 avril 2019
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
22 octobre 2021
Dernière mise à jour soumise répondant aux critères de contrôle qualité
21 octobre 2021
Dernière vérification
1 octobre 2021
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 17-23446
- NCI-2018-02204 (Identificateur de registre: NCI Clinical Trials Reporting Program (CTRP))
- 18801 (University of California, San Francisco)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Non
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur La douleur
-
Evergrain, LLCINQUIS Clinical Research Ltd.ComplétéSatiété du pain riche en fibres et riche en protéinesCanada
-
Tel-Aviv Sourasky Medical CenterWeizmann Institute of ScienceComplétéChangements de poids corporel | Modification alimentaire | Microbiote gastro-intestinal | Pain | Tests hématologiquesIsraël
-
University of BergenUniversity of Leipzig; Chalmers University of Technology; Nofima; Paderborn UniversityComplétéHyperglycémie | Prédiabète | Contrôle glycémique | PainNorvège
-
Ege UniversityComplétéObésité | Index glycémique | Glucose sanguin | PainTurquie